Dr. Lal Pathlabs Share Price
Sector: Healthcare Facilities
2907.75 +87.45 (3.10%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2822.95
Today’s High
2925
52 Week Low
1943.2
52 Week High
2889.45
2905.65 +84.60 (3.00%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2822.1
Today’s High
2926.95
52 Week Low
1943.7
52 Week High
2889
Key Metrics
- Market Cap (In Cr) 23475.53
- Beta 0.74
- Div. Yield (%) 0.85
- P/B 12.69
- TTM P/E 52.57
- Peg Ratio 3.8
- Sector P/E 26.76
- D/E 0.13
- Open Price 2822.95
- Prev Close 2820.3
Dr. Lal Pathlabs Analysis
Price Analysis
-
1 Week2.71%
-
3 Months23.1%
-
6 Month6.94%
-
YTD9.44%
-
1 Year25.88%
Risk Meter
- 29% Low risk
- 29% Moderate risk
- 29% Balanced Risk
- 29% High risk
- 29% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 3
- 3
- 3
- 1
- Buy
- 9
- 9
- 9
- 4
- Hold
- 2
- 2
- 2
- 2
- Sell
- 4
- 4
- 4
- 5
- Strong Sell
- 3
- 3
- 3
- 5
- Total
- 21
- 21
- 21
- 17
Dr. Lal Pathlabs News
Stocks to Buy: Asian Paints, PNC Infratech among top 10 picks by Centrum Broking
4 min read . 26 Jun 2024Stocks to buy: Axis Bank, Zydus, among 4 stock picks by SMC Global for this week
4 min read . 11 Jun 2024Dividend stocks: Dr. Lal PathLabs, Nelco shares to trade ex-dividend today
1 min read . 10 Jun 2024HDFC Securities initiates coverage on these healthcare stocks with 'buy' rating
3 min read . 20 May 2024Dr. Lal Pathlabs Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2226.6
- Selling/ General/ Admin Expenses Total
- 737.5
- Depreciation/ Amortization
- 143.6
- Other Operating Expenses Total
- 428.4
- Total Operating Expense
- 1760.9
- Operating Income
- 465.7
- Net Income Before Taxes
- 505.5
- Net Income
- 357.7
- Diluted Normalized EPS
- 42.98
- Period
- 2024
- Total Assets
- 2456
- Total Liabilities
- 606.7
- Total Equity
- 1849.3
- Tangible Book Valueper Share Common Eq
- 119.79
- Period
- 2024
- Cashfrom Operating Activities
- 535.4
- Cashfrom Investing Activities
- -24.3
- Cashfrom Financing Activities
- -413.9
- Net Changein Cash
- 97.2
- Period
- 2023
- Total Revenue
- 2016.88
- Selling/ General/ Admin Expenses Total
- 1016.91
- Depreciation/ Amortization
- 150.19
- Other Operating Expenses Total
- 37.08
- Total Operating Expense
- 1677.24
- Operating Income
- 339.64
- Net Income Before Taxes
- 343.83
- Net Income
- 238.85
- Diluted Normalized EPS
- 28.67
- Period
- 2023
- Total Assets
- 2385.56
- Total Liabilities
- 719.26
- Total Equity
- 1666.3
- Tangible Book Valueper Share Common Eq
- 91.66
- Period
- 2023
- Cashfrom Operating Activities
- 456.03
- Cashfrom Investing Activities
- -287.31
- Cashfrom Financing Activities
- -283.18
- Net Changein Cash
- -114.46
- Period
- 2022
- Total Revenue
- 2087.41
- Selling/ General/ Admin Expenses Total
- 962.59
- Depreciation/ Amortization
- 108.11
- Other Operating Expenses Total
- 37.81
- Total Operating Expense
- 1632.88
- Operating Income
- 454.53
- Net Income Before Taxes
- 474.98
- Net Income
- 344.83
- Diluted Normalized EPS
- 41.63
- Period
- 2022
- Total Assets
- 2346.75
- Total Liabilities
- 845.14
- Total Equity
- 1501.61
- Tangible Book Valueper Share Common Eq
- 66.17
- Period
- 2022
- Cashfrom Operating Activities
- 446.69
- Cashfrom Investing Activities
- -449.25
- Cashfrom Financing Activities
- 136.45
- Net Changein Cash
- 133.9
- Period
- 2021
- Total Revenue
- 1581.27
- Selling/ General/ Admin Expenses Total
- 699.12
- Depreciation/ Amortization
- 77.2
- Other Operating Expenses Total
- 29.81
- Total Operating Expense
- 1222.01
- Operating Income
- 359.25
- Net Income Before Taxes
- 394.41
- Net Income
- 291.62
- Diluted Normalized EPS
- 35.26
- Period
- 2021
- Total Assets
- 1661.33
- Total Liabilities
- 416.27
- Total Equity
- 1245.06
- Tangible Book Valueper Share Common Eq
- 133.16
- Period
- 2021
- Cashfrom Operating Activities
- 398.15
- Cashfrom Investing Activities
- -212.02
- Cashfrom Financing Activities
- -138.56
- Net Changein Cash
- 47.58
- Period
- 2020
- Total Revenue
- 1330.36
- Selling/ General/ Admin Expenses Total
- 643.15
- Depreciation/ Amortization
- 72.81
- Other Operating Expenses Total
- 28.18
- Total Operating Expense
- 1059.59
- Operating Income
- 270.77
- Net Income Before Taxes
- 310.5
- Net Income
- 225.94
- Diluted Normalized EPS
- 27.36
- Period
- 2020
- Total Assets
- 1374.31
- Total Liabilities
- 341.5
- Total Equity
- 1032.81
- Tangible Book Valueper Share Common Eq
- 110.4
- Period
- 2020
- Cashfrom Operating Activities
- 283.89
- Cashfrom Investing Activities
- -26.11
- Cashfrom Financing Activities
- -190.44
- Net Changein Cash
- 67.33
- Period
- 2019
- Total Revenue
- 1203.42
- Selling/ General/ Admin Expenses Total
- 603.66
- Depreciation/ Amortization
- 38.22
- Other Operating Expenses Total
- 28.01
- Total Operating Expense
- 947.98
- Operating Income
- 255.44
- Net Income Before Taxes
- 300.55
- Net Income
- 199.18
- Diluted Normalized EPS
- 24.14
- Period
- 2019
- Total Assets
- 1090.5
- Total Liabilities
- 145
- Total Equity
- 945.5
- Tangible Book Valueper Share Common Eq
- 108.93
- Period
- 2019
- Cashfrom Operating Activities
- 218.54
- Cashfrom Investing Activities
- -99.74
- Cashfrom Financing Activities
- -55.26
- Net Changein Cash
- 63.54
- Period
- 2024-03-31
- Total Revenue
- 545.4
- Selling/ General/ Admin Expenses Total
- 181
- Depreciation/ Amortization
- 36.6
- Other Operating Expenses Total
- 110.8
- Total Operating Expense
- 437.3
- Operating Income
- 108.1
- Net Income Before Taxes
- 119.9
- Net Income
- 84.5
- Diluted Normalized EPS
- 10.12
- Period
- 2024-03-31
- Total Assets
- 2456
- Total Liabilities
- 606.7
- Total Equity
- 1849.3
- Tangible Book Valueper Share Common Eq
- 119.79
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 535.4
- Cashfrom Investing Activities
- -24.3
- Cashfrom Financing Activities
- -413.9
- Net Changein Cash
- 97.2
- Period
- 2023-12-31
- Total Revenue
- 538.9
- Selling/ General/ Admin Expenses Total
- 186.7
- Depreciation/ Amortization
- 36
- Other Operating Expenses Total
- 104.6
- Total Operating Expense
- 434.3
- Operating Income
- 104.6
- Net Income Before Taxes
- 115.9
- Net Income
- 81.3
- Diluted Normalized EPS
- 9.76
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 601.3
- Selling/ General/ Admin Expenses Total
- 190.6
- Depreciation/ Amortization
- 35.9
- Other Operating Expenses Total
- 110.5
- Total Operating Expense
- 459.4
- Operating Income
- 141.9
- Net Income Before Taxes
- 152.2
- Net Income
- 109.3
- Diluted Normalized EPS
- 13.12
- Period
- 2023-09-30
- Total Assets
- 2445.3
- Total Liabilities
- 673.1
- Total Equity
- 1772.2
- Tangible Book Valueper Share Common Eq
- 107.54
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 305.4
- Cashfrom Investing Activities
- -205.3
- Cashfrom Financing Activities
- -243.8
- Net Changein Cash
- -143.7
- Period
- 2023-06-30
- Total Revenue
- 541
- Selling/ General/ Admin Expenses Total
- 179.2
- Depreciation/ Amortization
- 35.1
- Other Operating Expenses Total
- 102.5
- Total Operating Expense
- 429.9
- Operating Income
- 111.1
- Net Income Before Taxes
- 117.5
- Net Income
- 82.6
- Diluted Normalized EPS
- 9.93
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 490.98
- Selling/ General/ Admin Expenses Total
- 161.36
- Depreciation/ Amortization
- 37.59
- Other Operating Expenses Total
- 108.24
- Total Operating Expense
- 413.04
- Operating Income
- 77.94
- Net Income Before Taxes
- 83.13
- Net Income
- 56.65
- Diluted Normalized EPS
- 6.82
- Period
- 2023-03-31
- Total Assets
- 2385.56
- Total Liabilities
- 719.26
- Total Equity
- 1666.3
- Tangible Book Valueper Share Common Eq
- 91.66
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 456.03
- Cashfrom Investing Activities
- -287.31
- Cashfrom Financing Activities
- -283.18
- Net Changein Cash
- -114.46
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Dr. Lal Pathlabs Technical
Moving Average
SMA
- 5 Day2776.06
- 10 Day2733.22
- 20 Day2744.57
- 50 Day2573.28
- 100 Day2432.86
- 300 Day2473.71
Dr. Lal Pathlabs Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Fortis Healthcare
- 470.45
- -0.1
- -0.02
- 509.85
- 308.25
- 35517.01
- Narayana Hrudayalaya
- 1242.75
- 17.6
- 1.44
- 1445.05
- 972.05
- 25240.23
- Dr. Lal Pathlabs
- 2907.75
- 87.45
- 3.1
- 2889.45
- 1943.2
- 24196.28
- Aster DM Healthcare
- 345
- -1.9
- -0.55
- 430.11
- 213.44
- 17173.17
- Krishna Instit Of Medical Sciences
- 2133.75
- 12.55
- 0.59
- 2357
- 1625.05
- 17075.97
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Fortis Healthcare
- 59.13
- 4.53
- 5.07
- 7.63
- Narayana Hrudayalaya
- 31.46
- 8.61
- 23.44
- 9.72
- Dr. Lal Pathlabs
- 64.67
- 12.51
- 21.32
- 15.99
- Aster DM Healthcare
- 142.1
- 3.82
- 6.24
- 4.26
- Krishna Instit Of Medical Sciences
- 54.04
- 9.17
- 22.79
- 15.53
Dr. Lal Pathlabs Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 10-May-24
- Audited Results & Final Dividend
- 01-Feb-24
- Quarterly Results & Interim Dividend
- 02-Nov-23
- Quarterly Results
- 27-Jul-23
- Quarterly Results & Interim Dividend
- 11-May-23
- Audited Results & Final Dividend
- 02-Feb-23
- Quarterly Results
- 08-Nov-22
- Quarterly Results
- 28-Jul-22
- Quarterly Results & Interim Dividend
- 17-May-22
- Audited Results & Final Dividend
- 10-Feb-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 12-Sept-23
- 27-Jul-23
- AGM
- 12-Mar-23
- 08-Feb-23
- POM
- 30-Jun-22
- 17-May-22
- AGM
- 29-Jul-21
- 21-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 10-May-24
- 10-Jun-24
- 10-Jun-24
- 6
- 01-Feb-24
- 13-Feb-24
- 13-Feb-24
- 12
- 11-May-23
- 11-Aug-23
- 11-Aug-23
- 6
- 27-Jul-23
- 11-Aug-23
- 11-Aug-23
- 6
- 28-Jul-22
- 09-Aug-22
- 05-Aug-22
- 6
- 17-May-22
- 23-Jun-22
- 22-Jun-22
- 6
- 30-Jul-21
- 22-Aug-21
- 18-Aug-21
- 6
- 21-May-21
- 22-Jul-21
- 20-Jul-21
- 8
- 29-Jan-21
- 10-Feb-21
- 09-Feb-21
- 6
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)